X4 PHARMACEUTICALS INC (XFOR) Stock Analyst Ratings
NASDAQ:XFOR - Nasdaq - US98420X1037 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 84% to XFOR. The Buy consensus is the weighted average rating of the current analysts ratings.
XFOR was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about XFOR.
In the previous month the buy percentage consensus was at a similar level.
XFOR was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-26 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-02-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-14 | Stifel | Maintains | Buy -> Buy |
| 2024-11-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-31 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-04-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-12 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-17 | Stifel | Maintains | Buy -> Buy |
| 2023-05-05 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-10 | B. Riley Securities | Maintains | Buy |
| 2023-03-24 | Oppenheimer | Maintains | Outperform |
| 2023-03-22 | Cantor Fitzgerald | Maintains | Overweight |
| 2023-03-22 | HC Wainwright & Co. | Maintains | Buy |
| 2022-12-22 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-12-12 | Piper Sandler | Initiate | Overweight |
| 2022-11-30 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-19 | B. Riley Securities | Maintains | Buy |
| 2022-05-13 | HC Wainwright & Co. | Maintains | Buy |
| 2021-12-14 | HC Wainwright & Co. | Maintains | Buy |